DK1173179T3 - Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse - Google Patents

Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse

Info

Publication number
DK1173179T3
DK1173179T3 DK00922735T DK00922735T DK1173179T3 DK 1173179 T3 DK1173179 T3 DK 1173179T3 DK 00922735 T DK00922735 T DK 00922735T DK 00922735 T DK00922735 T DK 00922735T DK 1173179 T3 DK1173179 T3 DK 1173179T3
Authority
DK
Denmark
Prior art keywords
saredutant
prevention
treatment
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
DK00922735T
Other languages
Danish (da)
English (en)
Inventor
Xavier Emonds-Alt
Philippe Soubrie
Regis Steinberg
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK1173179T3 publication Critical patent/DK1173179T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DK00922735T 1999-04-27 2000-04-25 Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse DK1173179T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9905338A FR2792835B3 (fr) 1999-04-27 1999-04-27 Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
PCT/FR2000/001084 WO2000064423A2 (fr) 1999-04-27 2000-04-25 Utilisation du saredutant et de ses sels pharmaceutiquement acceptables dans le traitement ou la prevention des troubles de l'humeur d'adaptation et de l'anxiete-depression

Publications (1)

Publication Number Publication Date
DK1173179T3 true DK1173179T3 (da) 2003-07-14

Family

ID=9544931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00922735T DK1173179T3 (da) 1999-04-27 2000-04-25 Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse

Country Status (32)

Country Link
US (3) US6573281B1 (cs)
EP (1) EP1173179B1 (cs)
JP (1) JP2002542281A (cs)
KR (1) KR20020001850A (cs)
CN (1) CN1172669C (cs)
AR (1) AR023597A1 (cs)
AT (1) ATE234617T1 (cs)
AU (1) AU764304B2 (cs)
BG (1) BG65472B1 (cs)
BR (1) BR0010006A (cs)
CA (1) CA2370834C (cs)
CZ (1) CZ294904B6 (cs)
DE (1) DE60001725T2 (cs)
DK (1) DK1173179T3 (cs)
EE (1) EE05211B1 (cs)
ES (1) ES2193065T3 (cs)
FR (1) FR2792835B3 (cs)
HU (1) HUP0200969A3 (cs)
IL (1) IL145269A0 (cs)
MX (1) MXPA01010904A (cs)
NO (1) NO20015228L (cs)
NZ (1) NZ513851A (cs)
PL (1) PL196479B1 (cs)
PT (1) PT1173179E (cs)
RU (1) RU2238726C2 (cs)
SI (1) SI1173179T1 (cs)
SK (1) SK285459B6 (cs)
TR (1) TR200102512T2 (cs)
TW (1) TWI225399B (cs)
UA (1) UA69441C2 (cs)
WO (1) WO2000064423A2 (cs)
ZA (1) ZA200107143B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
US6903092B2 (en) 2000-04-06 2005-06-07 Peter Bernstein Naphthamide neurokinin antagonists for use as medicaments
US6846814B2 (en) 2000-04-06 2005-01-25 Astra Zeneca Ab Neurokinin antagonists for use as medicaments
JP2003530381A (ja) * 2000-04-06 2003-10-14 アストラゼネカ・アクチエボラーグ 化合物
ATE400563T1 (de) * 2000-04-06 2008-07-15 Astrazeneca Ab Neue neurokinin-antagonisten zum gebrauch als arzneimittel
GB0019008D0 (en) * 2000-08-04 2000-09-27 Astrazeneca Ab Therapeutic compounds
SE0003476D0 (sv) * 2000-09-28 2000-09-28 Astrazeneca Ab Compounds
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
FR2904221B1 (fr) * 2006-07-31 2008-09-12 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et la fluoxetine.
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
FR2912058A1 (fr) * 2007-02-07 2008-08-08 Sanofi Aventis Sa Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles
KR101174980B1 (ko) * 2007-09-14 2012-08-17 에프. 호프만-라 로슈 아게 Ｎｋ３ 수용체 길항제로서의 피페리딘 유도체
US20090076083A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched saredutant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2695626B1 (fr) * 1992-09-17 1994-12-02 Lebroch Yannick Dispositif de gobelet adaptable sur un conteneur de boisson.
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2700472B1 (fr) 1993-01-19 1995-02-17 Rhone Poulenc Rorer Sa Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2.
US5512680A (en) * 1993-02-26 1996-04-30 Sanofi Process for the preparation of an optically pure aminoalcohol
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
US5554644A (en) * 1994-06-08 1996-09-10 Warner-Lambert Company Tachykinin (NK2) antagonists
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression

Also Published As

Publication number Publication date
US20030176462A1 (en) 2003-09-18
US6573281B1 (en) 2003-06-03
UA69441C2 (uk) 2004-09-15
CZ294904B6 (cs) 2005-04-13
CA2370834A1 (en) 2000-11-02
KR20020001850A (ko) 2002-01-09
SK285459B6 (sk) 2007-02-01
PL351922A1 (en) 2003-06-30
ATE234617T1 (de) 2003-04-15
EE05211B1 (et) 2009-10-15
TWI225399B (en) 2004-12-21
US7390823B2 (en) 2008-06-24
EP1173179B1 (fr) 2003-03-19
CA2370834C (en) 2007-09-25
SK15472001A3 (sk) 2002-03-05
BR0010006A (pt) 2002-01-15
HK1041821A1 (en) 2002-07-26
WO2000064423A2 (fr) 2000-11-02
EP1173179A2 (fr) 2002-01-23
DE60001725D1 (de) 2003-04-24
RU2238726C2 (ru) 2004-10-27
PT1173179E (pt) 2003-06-30
US20080227818A1 (en) 2008-09-18
ES2193065T3 (es) 2003-11-01
NO20015228D0 (no) 2001-10-25
AR023597A1 (es) 2002-09-04
NO20015228L (no) 2001-12-21
AU4303400A (en) 2000-11-10
FR2792835A1 (fr) 2000-11-03
IL145269A0 (en) 2002-06-30
CZ20013812A3 (cs) 2002-02-13
BG65472B1 (bg) 2008-09-30
CN1348371A (zh) 2002-05-08
HUP0200969A3 (en) 2004-03-01
NZ513851A (en) 2003-04-29
DE60001725T2 (de) 2004-02-05
JP2002542281A (ja) 2002-12-10
EE200100553A (et) 2003-02-17
ZA200107143B (en) 2002-10-30
SI1173179T1 (en) 2003-06-30
MXPA01010904A (es) 2002-06-21
FR2792835B3 (fr) 2001-05-25
TR200102512T2 (tr) 2002-04-22
WO2000064423A3 (fr) 2001-04-19
PL196479B1 (pl) 2008-01-31
CN1172669C (zh) 2004-10-27
BG105962A (en) 2002-05-31
AU764304B2 (en) 2003-08-14
HUP0200969A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
NO996352D0 (no) <Kappa>-antagenist-forbindelser, farmasoeytiske sammensetninger og fremgangsmåte for forebygging og behandling av pruritus
PT1144395E (pt) Derivados de 2-aminobenzoxazinona para o tratamento da obesidade
NO20014046D0 (no) Gabapentinderivater for forhindring og behandling av visceral smerte
DK2412368T3 (da) Sammensætning til behandling af ar
NO20001870L (no) Ny fremgangsmÕte for behandling
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
ID28050A (id) Alat kesehatan
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
DK1278540T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose
DK0873308T3 (da) O-Carbamoyl-phenylalaninol-forbindelser og deres farmaceutisk anvendelige salte
NO20013409D0 (no) Anvendelse av pyrimidin-derivater for forhindring og behandling av cerebral ischemi
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO20012106D0 (no) Middel for behandling av benpatobolisme
DK1355668T3 (da) Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom
NO20013337L (no) Ny behandling
NO994258D0 (no) Anvendelse av levobupivakain eller ropivakain for behandling av migrene
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
DK1534296T3 (da) Anvendelse af cilobradin eller de farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt
PT1051172E (pt) Metodo para tratamento da dpco
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc